KENNETH R PITZER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KENNETH R PITZER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH R PITZER. KENNETH R PITZER is SVP, Prod Strat & Comm Plng in Theravance Biopharma, Inc. ($TBPH).
Latest Insider Trading Transactions of KENNETH R PITZER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 10 2021 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 65,000 | 0 | 400,280 | 335.3 K to 400.3 K (+19.39 %) |
Aug 24 2020 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 18.22 | 4,804 | 87,529 | 340,087 | 344.9 K to 340.1 K (-1.39 %) |
May 22 2020 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 26.67 | 4,807 | 128,203 | 344,891 | 349.7 K to 344.9 K (-1.37 %) |
Feb 24 2020 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 25.90 | 29,136 | 754,622 | 349,698 | 378.8 K to 349.7 K (-7.69 %) |
Feb 05 2020 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 54,000 | 0 | 378,834 | 324.8 K to 378.8 K (+16.62 %) |
Feb 05 2020 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 65,000 | 0 | 324,834 | 259.8 K to 324.8 K (+25.02 %) |
Aug 22 2019 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 21.51 | 2,272 | 48,871 | 262,106 | 264.4 K to 262.1 K (-0.86 %) |
May 22 2019 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 19.84 | 2,272 | 45,076 | 264,378 | 266.7 K to 264.4 K (-0.85 %) |
Feb 22 2019 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 27.00 | 3,674 | 99,198 | 266,650 | 270.3 K to 266.7 K (-1.36 %) |
Feb 07 2019 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 47,250 | 0 | 270,324 | 223.1 K to 270.3 K (+21.18 %) |
Feb 07 2019 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 65,000 | 0 | 223,074 | 158.1 K to 223.1 K (+41.12 %) |
Nov 21 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 24.79 | 3,908 | 96,879 | 158,074 | 162 K to 158.1 K (-2.41 %) |
Aug 22 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 26.95 | 5,043 | 135,909 | 161,982 | 167 K to 162 K (-3.02 %) |
May 22 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 24.31 | 18,779 | 456,517 | 167,025 | 185.8 K to 167 K (-10.11 %) |
May 16 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 33,750 | 0 | 185,804 | 152.1 K to 185.8 K (+22.20 %) |
Feb 22 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 29.09 | 4,252 | 123,691 | 152,054 | 156.3 K to 152.1 K (-2.72 %) |
Feb 14 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 9,000 | 0 | 156,306 | 147.3 K to 156.3 K (+6.11 %) |
Nov 22 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 28.58 | 5,014 | 143,300 | 147,306 | 152.3 K to 147.3 K (-3.29 %) |
Aug 22 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 27.40 | 5,013 | 137,356 | 152,320 | 157.3 K to 152.3 K (-3.19 %) |
May 23 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 36.83 | 5,014 | 184,666 | 157,333 | 162.3 K to 157.3 K (-3.09 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 33.78 | 10,030 | 338,813 | 162,347 | 172.4 K to 162.3 K (-5.82 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 9,000 | 0 | 172,377 | 163.4 K to 172.4 K (+5.51 %) |
Nov 22 2016 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 31.96 | 1,727 | 55,195 | 163,377 | 165.1 K to 163.4 K (-1.05 %) |
Aug 23 2016 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 27.89 | 1,729 | 48,222 | 165,104 | 166.8 K to 165.1 K (-1.04 %) |
May 24 2016 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 20.55 | 1,728 | 35,510 | 166,833 | 168.6 K to 166.8 K (-1.03 %) |
Mar 17 2016 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 105,000 | 0 | 168,561 | 63.6 K to 168.6 K (+165.20 %) |
Page: 1